Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIMAX: Perioperative FOLFOXIRI + Bevacizumab vs Postop FOLFOX for CRC Liver Metastases
NCT01540435Phase 2Withdrawn
- Sponsor
- University of Regensburg
- Start
- Sep 2012
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by University of Regensburg. Planned start Sep 2012; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01540435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01540435.